Chronic exposure to fluoxetine (Prozac) causes developmental delays in Rana pipiens larvae.
Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine, are among the many pharmaceuticals detected in aquatic ecosystems. Although the acute effects of SSRIs on select organisms have been reported, little is understood about the chronic effects of these drugs on amphibians, which are particularly sensitive to environmental pollutants. Serotonin plays important roles in many physiological functions, including a wide array of developmental processes. Exposure to SSRIs during development may cause developmental complications in a variety of organisms, but little is known about the degree of exposure necessary to cause deleterious effects. Here, we sought to gain a better understanding of the effects of SSRIs on amphibian development by use of a combined laboratory and outdoor mesocosm study. Tadpoles in a laboratory setting were exposed to a low (0.029 µg/L) and a high (0.29 µg/L) concentration of the common SSRI fluoxetine from stages 21 and 22 through completion of metamorphosis. Tadpoles in outdoor mesocosms were exposed to fluoxetine concentrations ranging from 0.1 to 0.3 µg/L. Exposed tadpoles in the laboratory showed delayed development compared with controls when stage was assessed throughout the experiment. Control tadpoles also gained weight faster than treatment tadpoles, which may be explained by reduced food intake. Mesocosm tadpoles exhibited similar trends, but no significant differences were detected. These results indicate that ecologically relevant levels of fluoxetine may cause developmental delays in amphibians.
Foster
Hannah R
HR
Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, Michigan 48109, USA. fosterh@umich.edu
Burton
G Allen
GA
Basu
Niladri
N
Werner
Earl E
EE
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005473:Fluoxetine / Q000633:toxicity*; D007814:Larva / Q000187:drug effects / Q000254:growth & development; D011894:Rana pipiens / Q000002:abnormalities* / Q000254:growth & development*; D017367:Selective Serotonin Reuptake Inhibitors / Q000633:toxicity*; D036401:Toxicity Tests, Chronic; D014874:Water Pollutants, Chemical / Q000633:toxicity*
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D014874:Water Pollutants, Chemical